DONOVAN JOANNE M. (CMO) sold 92.7% of their position (55.23K shares) of EDGEWISE THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.09M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/5/2026ACC: 0001644087-26-000004
Officer· CMO
Since Apr 2021
-55.23K
Net shares
Net seller
$2.09M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
50K acquired · 105.23K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−5.23K
Price / share
$31.29
Trade value
$163.66K
% of position
54.5%
5/4/2026
9.60K→4.37K
Common Stock
Direct
Shares
+50K
Price / share
$7.08
Trade value
$354K
% of position
1145.0%
5/5/2026
4.37K→54.37K
Common Stock
Direct
Shares
−50K
Price / share
$38.57
Trade value
$1.93M
% of position
92.0%
5/5/2026
54.37K→4.37K
Total
Net shares
−5.23K
Net value
-$1.74M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/4/2026 | S · Sale | −5.23K | $31.29 | $163.66K | 54.5% | 9.60K | 4.37K |
| Common Stock Direct | 5/5/2026 | M · Option Exercise | +50K | $7.08 | $354K | 1145.0% | 4.37K | 54.37K |
| Common Stock Direct | 5/5/2026 | S · Sale | −50K | $38.57 | $1.93M | 92.0% | 54.37K | 4.37K |
| Total | −5.23K | -$1.74M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
7.08
Held after
75K
Exercisable
—
5/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock50K shares | 5/5/2026 | M · Option Exercise | −50K | 7.08 | — | 75K |